Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, MI 48109, USA; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Professor Gama Pinto, 1649-003 Lisboa, Portugal.
Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, MI 48109, USA; Department Engineering Pharmacy Section, Miguel Hernandez University, San Juan de Alicante, 03550 Alicante, Spain.
Eur J Pharm Biopharm. 2018 Aug;129:162-174. doi: 10.1016/j.ejpb.2018.05.033. Epub 2018 May 29.
The goal of this study was to create a mass transport model (MTM) model for gastric emptying and upper gastrointestinal (GI) appearance that can capture the in vivo concentration-time profiles of the nonabsorbable drug phenol red in solution in the stomach and upper small intestine by direct luminal measurement while simultaneously recording the contractile activity (motility) via manometry. We advanced from a one-compartmental design of the stomach to a much more appropriate, multi-compartmental 'mixing tank' gastric model that reflects drug distribution along the different regions of the stomach as a consequence of randomly dosing relative to the different contractile phases of the migrating motor complex (MMC). To capture the intraluminal phenol red concentrations in the different segments of the GI tract both in fasted and fed state conditions, it was essential to include a bypass flow compartment ('magenstrasse') to facilitate the transport of the phenol red solution directly to the duodenum (fasted state) or antrum (fed state). The fasted and fed state models were validated with external reference data from an independent aspiration study using another nonabsorbable marker (paromomycin). These results will be essential for the development and optimization of computational programs for GI simulation and absorption prediction, providing a realistic gastric physiologically-based pharmacokinetic (PBPK) model based on direct measurement of gastric concentrations of the drug in the stomach.
本研究的目的是创建一个可用于胃排空和上胃肠道(GI)显影的质量传递模型(MTM),该模型可通过直接腔内测量来捕获胃和上小肠中溶液中非吸收性药物苯酚红的体内浓度-时间曲线,同时通过测压法记录收缩活动(动力)。我们从胃的单室设计推进到更合适的多室“混合罐”胃模型,该模型反映了药物在胃的不同区域的分布情况,这是由于相对于移行性运动复合波(MMC)的不同收缩相随机给药所致。为了在禁食和进食状态下捕获 GI 道不同节段腔内的苯酚红浓度,必须包括旁路流隔室(“magenstrasse”),以促进苯酚红溶液直接输送到十二指肠(禁食状态)或胃窦(进食状态)。使用另一种不可吸收的标记物(巴龙霉素)进行的独立抽吸研究的外部参考数据对禁食和进食状态模型进行了验证。这些结果对于 GI 模拟和吸收预测的计算程序的开发和优化至关重要,为基于药物在胃中浓度的直接测量的胃生理药代动力学(PBPK)模型提供了现实基础。